Drug Type Small molecule drug |
Synonyms D 1927 |
Target |
Action inhibitors |
Mechanism MMPs inhibitors(Matrix metalloproteinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H36N4O5S |
InChIKeyJSAZXDIRFNTFPR-GRDNDAEWSA-N |
CAS Registry265988-36-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Phase 1 | - | - | |
Neoplasms | Phase 1 | United Kingdom | - | |
Rheumatoid Arthritis | Phase 1 | United Kingdom | - | |
Rheumatoid Arthritis | Phase 1 | - | - | |
Dystrophy, Macular | Preclinical | United Kingdom | - |